Table 2.

Immunosuppressive treatments

Treatment	All Patients, n=112	Minimal or Negative Hematuria during Follow-Up, n=66	Persistent Hematuria during Follow-Up, n=46	P Value
IS treatments (%)	44 (39)	23 (34)	21 (45)	0.24
CS monotherapy	12 (27)	7 (30)	5 (24)	0.96
CS + MMF	27 (61)	15 (65)	12 (57)	0.68
CS + AZA	3 (7)	—	3 (14)
CS + CYC	2 (5)	1 (5)	1 (5)	0.79
Duration of CS treatment, moa	7.3±6.6	6.6±1.6	6.8±1.5	0.70
Cumulative dose of CS, mg/kgb	58 (31–69)	61 (43–67)	49 (28–81)	0.37

IS, immunosuppressive; CS, corticosteroid; MMF, mycophenolate mofetil; AZA, azathioprine; CYC, cyclophosphamide.

^aMean±SD.

^bMedian (interquartile range).